Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
Sobrero
A
A
Cattedra di Oncologia Medica, Università di Udine, Italy.
Guglielmi
A
A
Grossi
F
F
Puglisi
F
F
Aschele
C
C
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D011355:Prodrugs; D005641:Tegafur / Q000494:pharmacology / Q000627:therapeutic use; D014498:Uracil / Q000494:pharmacology / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D005493:Folic Acid Antagonists; D011355:Prodrugs; D005641:Tegafur; D014498:Uracil; D002955:Leucovorin; D005472:Fluorouracil